Cargando…
Identification and quantification of change in Australian illicit drug markets
BACKGROUND: In early 2001 Australia experienced a sudden reduction in the availability of heroin which had widespread effects on illicit drug markets across the country. The consequences of this event, commonly referred to as the Australian 'heroin shortage', have been extensively studied...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1555593/ https://www.ncbi.nlm.nih.gov/pubmed/16884546 http://dx.doi.org/10.1186/1471-2458-6-200 |
_version_ | 1782129361181212672 |
---|---|
author | Gilmour, Stuart Koch, Inge Degenhardt, Louisa Day, Carolyn |
author_facet | Gilmour, Stuart Koch, Inge Degenhardt, Louisa Day, Carolyn |
author_sort | Gilmour, Stuart |
collection | PubMed |
description | BACKGROUND: In early 2001 Australia experienced a sudden reduction in the availability of heroin which had widespread effects on illicit drug markets across the country. The consequences of this event, commonly referred to as the Australian 'heroin shortage', have been extensively studied and there has been considerable debate as to the causes of the shortage and its implications for drug policy. This paper aims to investigate the presence of these epidemic patterns, to quantify the scale over which they occur and to estimate the relative importance of the 'heroin shortage' and any epidemic patterns in the drug markets. METHOD: Key indicator data series from the New South Wales illicit drug market were analysed using the statistical methods Principal Component Analysis and SiZer. RESULTS: The 'heroin shortage' represents the single most important source of variation in this illicit drug market. Furthermore the size of the effect of the heroin shortage is more than three times that evidenced by long-term 'epidemic' patterns. CONCLUSION: The 'heroin shortage' was unlikely to have been a simple correction at the end of a long period of reduced heroin availability, and represents a separate non-random shock which strongly affected the markets. |
format | Text |
id | pubmed-1555593 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-15555932006-08-26 Identification and quantification of change in Australian illicit drug markets Gilmour, Stuart Koch, Inge Degenhardt, Louisa Day, Carolyn BMC Public Health Research Article BACKGROUND: In early 2001 Australia experienced a sudden reduction in the availability of heroin which had widespread effects on illicit drug markets across the country. The consequences of this event, commonly referred to as the Australian 'heroin shortage', have been extensively studied and there has been considerable debate as to the causes of the shortage and its implications for drug policy. This paper aims to investigate the presence of these epidemic patterns, to quantify the scale over which they occur and to estimate the relative importance of the 'heroin shortage' and any epidemic patterns in the drug markets. METHOD: Key indicator data series from the New South Wales illicit drug market were analysed using the statistical methods Principal Component Analysis and SiZer. RESULTS: The 'heroin shortage' represents the single most important source of variation in this illicit drug market. Furthermore the size of the effect of the heroin shortage is more than three times that evidenced by long-term 'epidemic' patterns. CONCLUSION: The 'heroin shortage' was unlikely to have been a simple correction at the end of a long period of reduced heroin availability, and represents a separate non-random shock which strongly affected the markets. BioMed Central 2006-08-03 /pmc/articles/PMC1555593/ /pubmed/16884546 http://dx.doi.org/10.1186/1471-2458-6-200 Text en Copyright © 2006 Gilmour et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Gilmour, Stuart Koch, Inge Degenhardt, Louisa Day, Carolyn Identification and quantification of change in Australian illicit drug markets |
title | Identification and quantification of change in Australian illicit drug markets |
title_full | Identification and quantification of change in Australian illicit drug markets |
title_fullStr | Identification and quantification of change in Australian illicit drug markets |
title_full_unstemmed | Identification and quantification of change in Australian illicit drug markets |
title_short | Identification and quantification of change in Australian illicit drug markets |
title_sort | identification and quantification of change in australian illicit drug markets |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1555593/ https://www.ncbi.nlm.nih.gov/pubmed/16884546 http://dx.doi.org/10.1186/1471-2458-6-200 |
work_keys_str_mv | AT gilmourstuart identificationandquantificationofchangeinaustralianillicitdrugmarkets AT kochinge identificationandquantificationofchangeinaustralianillicitdrugmarkets AT degenhardtlouisa identificationandquantificationofchangeinaustralianillicitdrugmarkets AT daycarolyn identificationandquantificationofchangeinaustralianillicitdrugmarkets |